Ramucirumab(LY3009806, IMC-1121B, trade name Cyramza) is a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors. This drug was developed by ImClone Systems Inc. It was isolated from a native phage display library from Dyax.
Category:
Ramucirumab Vial for injection Brand:
Lilly Product Code:
Availability:
Available